Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Racial Disparities in the Molecular Landscape of Cancer

ELISABETH I. HEATH, FILIPA LYNCE, JOANNE XIU, ANGELA ELLERBROCK, SANDEEP K. REDDY, ELIAS OBEID, STEPHEN V. LIU, ALICCIA BOLLIG-FISCHER, DUSKA SEPAROVIC and ARI VANDERWALDE
Anticancer Research April 2018, 38 (4) 2235-2240;
ELISABETH I. HEATH
1Karmanos Cancer Institute, Department of Oncology, Wayne State University School of Medicine, Detroit, MI, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: heathe@karmanos.org
FILIPA LYNCE
2Lombardi Comprehensive Cancer Center, Division of Hematology and Oncology, Department of Medicine, Georgetown University Medical Center, Washington, DC, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JOANNE XIU
3Caris Life Sciences, Phoenix, AZ, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ANGELA ELLERBROCK
3Caris Life Sciences, Phoenix, AZ, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SANDEEP K. REDDY
4NantHealth, Culver City, CA, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ELIAS OBEID
5Fox Chase Cancer Center, Department of Clinical Genetics, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
STEPHEN V. LIU
2Lombardi Comprehensive Cancer Center, Division of Hematology and Oncology, Department of Medicine, Georgetown University Medical Center, Washington, DC, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ALICCIA BOLLIG-FISCHER
1Karmanos Cancer Institute, Department of Oncology, Wayne State University School of Medicine, Detroit, MI, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DUSKA SEPAROVIC
1Karmanos Cancer Institute, Department of Oncology, Wayne State University School of Medicine, Detroit, MI, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ARI VANDERWALDE
6West Cancer Center, Division of Hematology and Oncology, Department of Medicine, University of Tennessee, Memphis, TN, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 38 no. 4 2235-2240
PubMed 
29599344

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received February 3, 2018
  • Revision received February 26, 2018
  • Accepted February 27, 2018
  • Published online March 29, 2018.

Copyright & Usage 
Copyright© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved

Author Information

  1. ELISABETH I. HEATH1⇑,
  2. FILIPA LYNCE2,
  3. JOANNE XIU3,
  4. ANGELA ELLERBROCK3,
  5. SANDEEP K. REDDY4,
  6. ELIAS OBEID5,
  7. STEPHEN V. LIU2,
  8. ALICCIA BOLLIG-FISCHER1,
  9. DUSKA SEPAROVIC1 and
  10. ARI VANDERWALDE6
  1. 1Karmanos Cancer Institute, Department of Oncology, Wayne State University School of Medicine, Detroit, MI, U.S.A.
  2. 2Lombardi Comprehensive Cancer Center, Division of Hematology and Oncology, Department of Medicine, Georgetown University Medical Center, Washington, DC, U.S.A.
  3. 3Caris Life Sciences, Phoenix, AZ, U.S.A.
  4. 4NantHealth, Culver City, CA, U.S.A.
  5. 5Fox Chase Cancer Center, Department of Clinical Genetics, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, U.S.A.
  6. 6West Cancer Center, Division of Hematology and Oncology, Department of Medicine, University of Tennessee, Memphis, TN, U.S.A.
  1. Correspondence to: Dr. Elisabeth I. Heath, Karmanos Cancer Institute, Department of Oncology, Wayne State University School of Medicine, 4100 John R, Detroit, MI 48201, U.S.A. Tel: +1 3135768624, Fax: +1 3135768767, e-mail: heathe{at}karmanos.org
View Full Text

Cited By...

  • 25 Citations
  • Google Scholar
PreviousNext
Back to top

In this issue

Anticancer Research: 38 (4)
Anticancer Research
Vol. 38, Issue 4
April 2018
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Racial Disparities in the Molecular Landscape of Cancer
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
3 + 16 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Racial Disparities in the Molecular Landscape of Cancer
ELISABETH I. HEATH, FILIPA LYNCE, JOANNE XIU, ANGELA ELLERBROCK, SANDEEP K. REDDY, ELIAS OBEID, STEPHEN V. LIU, ALICCIA BOLLIG-FISCHER, DUSKA SEPAROVIC, ARI VANDERWALDE
Anticancer Research Apr 2018, 38 (4) 2235-2240;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Racial Disparities in the Molecular Landscape of Cancer
ELISABETH I. HEATH, FILIPA LYNCE, JOANNE XIU, ANGELA ELLERBROCK, SANDEEP K. REDDY, ELIAS OBEID, STEPHEN V. LIU, ALICCIA BOLLIG-FISCHER, DUSKA SEPAROVIC, ARI VANDERWALDE
Anticancer Research Apr 2018, 38 (4) 2235-2240;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Poor Survival and Differential Impact of Genetic Features of Black Patients with Acute Myeloid Leukemia
  • Prevalence of the BRAF p.v600e variant in patients with colorectal cancer from Mexico and its estimated frequency in Latin American and Caribbean populations
  • PTEN Is Involved in Sunitinib and Sorafenib Resistance in Renal Cell Carcinoma
  • Google Scholar

More in this TOC Section

  • Role of 1p/19q Codeletion in Diffuse Low-grade Glioma Tumour Prognosis
  • Identification of Patients With Glioblastoma Who May Benefit from Hypofractionated Radiotherapy
  • Optimal Treatment of Hormone Receptor-positive Advanced Breast Cancer Patients With Palbociclib
Show more Clinical Studies

Similar Articles

Keywords

  • Cancer
  • mutational profiles
  • racial disparities
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire